In This Article:
We recently compiled a list of the 10 Micro-, Small-Cap Firms Were Last Week's Top Performers. In this article, we are going to take a look at where Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) stands against the other stocks.
Micro- and small-cap companies dominated the stock market last week, clocking in impressive gains on the back of a flurry of catalysts that boosted investing appetite.
We named last week’s top 10 performers that outperformed the Russell 2000 index, which dropped by 4.04 percent week-on-week. Among them, one firm particularly stood out with its outstanding 317-percent jump, thanks to a $1-billion deal that could fuel its growth prospects.
To come up with the list, we considered the stocks with the highest week-on-week change, comparing their share prices on March 7 and February 28.
We classified micro-cap companies as those with a market capitalization below $300 million and small-cap firms as those with a market capitalization below $2 billion.
A photograph of a customer testing out different products in the skincare aisle at a store.
Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH)
Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) surged by 46.7 percent last week to end at $7.69 on Friday versus the $5.24 closing week-on-week despite the lack of fresh catalysts to boost investing appetite.
Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH), a China-based company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, is also a newly listed firm on the US stock exchange, having debuted on December 27, 2024.
From its initial public offering price of $4 apiece, Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH)’s latest stock price already marked a 92.25-percent jump, signaling investor optimism.
Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) was able to raise $4.8 million from its IPO, with net proceeds intended to be used for expanding the scale of directly-owned stores in the PRC, purchasing existing product patents to develop proprietary products, and acquiring ingredient suppliers to reduce production costs over the long term.
Overall PHH ranks 8th on our list of last week's top performers. While we acknowledge the potential of PHH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PHH but trades at less than 5 times its earnings, check out our report about the cheapest AI stock.